Henry Mandeville

7PUBLICATIONS
91CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 10, 2025
The Spectrum of IDH- and H3-Wildtype High-Grade Glioma Subgroups Occurring across Teenage and Young Adult Patient Populations.

Rita Pereira, Alan Mackay, Yura Grabovska

|Mar 07, 2025
Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial.

Gianni Bisogno, Julia Chisholm, Raquel Hladun

|Feb 07, 2025
Reply to "Toward a reduction in the burden of therapy in patients with rhabdomyosarcoma. How much is enough?"

Henry C Mandeville, Gianni Bisogno, Veronique Minard-Colin

|Nov 15, 2024
Parameningeal Rhabdomyosarcoma: Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 Study.

Reineke A Schoot, Pieter Taselaar, Giovanni Scarzello

|Jul 26, 2024
Localized incompletely resected standard risk rhabdomyosarcoma in children and adolescents: Results from the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 trial.

Henry C Mandeville, Gianni Bisogno, Veronique Minard-Colin

|Sep 08, 2023
Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee.

Roelof van Ewijk, Cyrano Chatziantoniou, Madeleine Adams

Pageof 2

Frequent Collaborators

6 joint publications

Daniel Orbach

6 joint publications

Gianni Bisogno

6 joint publications

Veronique Minard-Colin

6 joint publications

Andrea Ferrari